Advertisement
Findings support need for personalized disease management
Tumor genomics offer clues for identifying high risk of relapse
DESTINY-Breast04 study leads to practice-changing findings
Low-strength electrical current identifies at-risk patients with greater accuracy than tape measurement
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Understudied Src Family Kinase may serve as a potential therapeutic target
Should institutions adopt “time to treatment” as a new quality metric?
Dr. Eng and colleagues will probe role of microbial/immune system interactions in cancer progression
CDX-011 shows promise for triple negative disease
Advertisement
Advertisement